Latest Nan Fung Group Holdings Ltd Stock Portfolio
$121Million– No. of Holdings #24
Nan Fung Group Holdings Ltd Performance:
2026 Q1: 7.66%YTD: 7.66%2025: 15.19%
Performance for 2026 Q1 is 7.66%, and YTD is 7.66%, and 2025 is 15.19%.
About Nan Fung Group Holdings Ltd and 13F Hedge Fund Stock Holdings
On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Nan Fung Group Holdings Ltd reported an equity portfolio of $121.3 Millions as of 31 Mar, 2026.
The top stock holdings of Nan Fung Group Holdings Ltd are , , . The fund has invested 27.3% of it's portfolio in EVOMMUNE INC and 16.3% of portfolio in MAPLIGHT THERAPEUTICS INC.
The fund managers got completely rid off STANDARD BIOTOOLS INC (LAB), REPLIMUNE GROUP INC (REPL) and BICYCLE THERAPEUTICS PLC (BCYC) stocks. They significantly reduced their stock positions in MADRIGAL PHARMACEUTICALS INC (MDGL), BOLT BIOTHERAPEUTICS INC (BOLT) and OCULIS HOLDING AG. Nan Fung Group Holdings Ltd opened new stock positions in CELCUITY INC (CELC) and INSMED INC (INSM). The fund showed a lot of confidence in some stocks as they added substantially to LB PHARMACEUTICALS INC.
The top stock holdings of Nan Fung Group Holdings Ltd are , , . The fund has invested 27.3% of it's portfolio in EVOMMUNE INC and 16.3% of portfolio in MAPLIGHT THERAPEUTICS INC.
The fund managers got completely rid off STANDARD BIOTOOLS INC (LAB), REPLIMUNE GROUP INC (REPL) and BICYCLE THERAPEUTICS PLC (BCYC) stocks. They significantly reduced their stock positions in MADRIGAL PHARMACEUTICALS INC (MDGL), BOLT BIOTHERAPEUTICS INC (BOLT) and OCULIS HOLDING AG. Nan Fung Group Holdings Ltd opened new stock positions in CELCUITY INC (CELC) and INSMED INC (INSM). The fund showed a lot of confidence in some stocks as they added substantially to LB PHARMACEUTICALS INC.
Nan Fung Group Holdings Ltd Equity Portfolio Value
Last Reported on: 14 May, 2026
Nan Fung Group Holdings Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Nan Fung Group Holdings Ltd made a return of 7.66% in the last quarter. In trailing 12 months, it's portfolio return was 30.11%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| celcuity inc | 3,230,160 |
| insmed inc | 1,075,960 |
New stocks bought by Nan Fung Group Holdings Ltd
Additions
| Ticker | % Inc. |
|---|---|
| lb pharmaceuticals inc | 110 |
Additions to existing portfolio by Nan Fung Group Holdings Ltd
Reductions
| Ticker | % Reduced |
|---|---|
| madrigal pharmaceuticals inc | -52.22 |
| bolt biotherapeutics inc | -49.87 |
| oculis holding ag | -31.85 |
| incyte corp | -8.95 |
Nan Fung Group Holdings Ltd reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| standard biotools inc | -2,410,470 |
| bicycle therapeutics plc | -488,116 |
| replimune group inc | -619,349 |
| bolt projs hldgs inc | -32,437 |
| rocket lab corp | -266,762 |
Nan Fung Group Holdings Ltd got rid off the above stocks
Sector Distribution
Nan Fung Group Holdings Ltd has about 71.4% of it's holdings in Others sector.
- Others
- Healthcare
- Technology
| Sector | % |
|---|---|
| Others | 71.4 |
| Healthcare | 26.1 |
| Technology | 2.5 |
Market Cap. Distribution
Nan Fung Group Holdings Ltd has about 13% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- LARGE-CAP
- MEGA-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 71.4 |
| MID-CAP | 13.3 |
| LARGE-CAP | 9.1 |
| MEGA-CAP | 3.9 |
| SMALL-CAP | 2 |
Stocks belong to which Index?
About 21.9% of the stocks held by Nan Fung Group Holdings Ltd either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 78.1 |
| RUSSELL 2000 | 17.7 |
| S&P 500 | 4.2 |
Nan Fung Group Holdings Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd has 24 stocks in it's portfolio. About 83.4% of the portfolio is in top 10 stocks. CYBN proved to be the most loss making stock for the portfolio. was the most profitable stock for Nan Fung Group Holdings Ltd last quarter.
Last Reported on: 14 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 1.89 | 102,984 | 2,292,420 | unchanged | 0.00 | ||
| ARGX | argenx se | 1.69 | 2,800 | 2,044,700 | unchanged | 0.00 | ||
| ASND | ascendis pharma a/s | 2.56 | 13,600 | 3,110,730 | unchanged | 0.00 | ||
| BCYC | bicycle therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BGNE | beone medicines ltd | 3.85 | 15,722 | 4,668,960 | unchanged | 0.00 | ||
| BOLT | bolt biotherapeutics inc | 0.10 | 29,250 | 118,170 | reduced | -49.87 | ||
| CELC | celcuity inc | 2.66 | 28,300 | 3,230,160 | new | |||
| CYBN | cybin inc | 1.82 | 460,000 | 2,208,000 | unchanged | 0.00 | ||
| HRMY | harmony biosciences hldgs in | 0.62 | 27,049 | 757,642 | unchanged | 0.00 | ||
| INCY | incyte corp | 4.17 | 53,742 | 5,058,200 | reduced | -8.95 | ||
| INSM | insmed inc | 0.89 | 6,580 | 1,075,960 | new | |||
| KYMR | kymera therapeutics inc | 2.12 | 30,875 | 2,571,580 | unchanged | 0.00 | ||
| LAB | standard biotools inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MDGL | madrigal pharmaceuticals inc | 2.45 | 5,672 | 2,969,120 | reduced | -52.22 | ||
| PCOR | procore technologies inc | 2.50 | 53,299 | 3,038,040 | unchanged | 0.00 | ||
| RANI | rani therapeutics hldgs inc | 0.30 | 493,584 | 362,686 | unchanged | 0.00 | ||
| REPL | replimune group inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RVMD | revolution medicines inc | 1.54 | 19,253 | 1,872,350 | unchanged | 0.00 | ||
| RXRX | recursion pharmaceuticals in | 1.51 | 595,287 | 1,827,530 | unchanged | 0.00 | ||
| RYTM | rhythm pharmaceuticals inc | 3.52 | 49,120 | 4,271,970 | unchanged | 0.00 | ||